Vaxcyte Inc (PCVX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2021 | 03-2021 | 12-2020 | 09-2020 | 06-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -44,899 | -21,220 | -89,217 | -68,480 | -47,462 |
| Depreciation Amortization | 1,876 | 678 | 1,405 | 1,073 | 739 |
| Accounts payable and accrued liabilities | 4,103 | 2,185 | 26,102 | 7,330 | -799 |
| Other Working Capital | -3,496 | 5,472 | 35,270 | 27,570 | 21,795 |
| Other Operating Activity | 531 | -320 | -20,188 | -3,353 | 2,922 |
| Operating Cash Flow | $-41,885 | $-13,205 | $-46,628 | $-35,860 | $-22,805 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -228,531 | -172,145 | N/A | N/A | N/A |
| PPE Investments | -3,454 | -1,246 | -1,105 | -383 | -404 |
| Sale Of Investment | 38,064 | N/A | N/A | N/A | N/A |
| Investing Cash Flow | $-193,921 | $-173,391 | $-1,105 | $-383 | $-404 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | 264,007 | 267,375 | 267,375 |
| Debt Repayment | N/A | N/A | -61 | -61 | -61 |
| Common Stock Issued | 1,443 | 487 | 1,045 | 490 | 382 |
| Other Financing Activity | 0 | 0 | 109,879 | 106,511 | 106,583 |
| Financing Cash Flow | $1,443 | $487 | $374,870 | $374,315 | $374,279 |
| Exchange Rate Effect | 30 | -281 | 87 | N/A | N/A |
| Beginning Cash Position | 386,200 | 386,200 | 58,976 | 58,976 | 58,976 |
| End Cash Position | 151,867 | 199,810 | 386,200 | 397,048 | 410,046 |
| Net Cash Flow | $-234,333 | $-186,390 | $327,224 | $338,072 | $351,070 |
| Free Cash Flow | |||||
| Operating Cash Flow | -41,885 | -13,205 | -46,628 | -35,860 | -22,805 |
| Capital Expenditure | -3,454 | -1,246 | -1,155 | -433 | -404 |
| Free Cash Flow | -45,339 | -14,451 | -47,783 | -36,293 | -23,209 |